Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.05.026Source: DataRank Database

Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment is a research paper published in Journal of Allergy and Clinical Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 90 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access90 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 21.35)OA: bronzeTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Patrick M. Schlievert ORCID,Takeshi Yoshida ORCID,Stephanie Lussier ORCID,Mark Boguniewicz ORCID,Tissa Hata ORCID

Live enrichment

PubMed:37315812 PMC:PMC10716365 OpenAlex:https://openalex.org/W4380301245

NIAID NIH HHS

Grant: U01 AI178772

NIAID NIH HHS

Grant: U19 AI117673

NIAID NIH HHS

Grant: U01 AI152011

NCATS NIH HHS

Grant: UL1 TR002535

NCATS NIH HHS

Grant: UM1 TR004399

NIAID NIH HHS

Grant: UM1 AI151958

NIAID NIH HHS

Grant: UM2 AI117870

NIAID

NCATS

FWCI

21.35

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttp://www.jacionline.org/article/S0091674923007546/pdf

publisherhttp://www.jacionline.org/article/S0091674923007546/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0091674923007546?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0091674923007546?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jaci.2023.05.026

Fields of Study

Dermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisGut microbiota and healthHumansDermatitis, AtopicStaphylococcus aureusAntibodies, Monoclonal, HumanizedSkinStaphylococcal InfectionsSeverity of Illness IndexTreatment Outcome

MeSH Terms

Dermatitis, AtopicHumansSeverity of Illness IndexSkinStaphylococcal InfectionsStaphylococcus aureusTreatment OutcomeAntibodies, Monoclonal, Humanized

Keywords

DupilumabAtopic dermatitisStaphylococcus aureusMedicineDermatologyReduction (mathematics)Methicillin-resistant Staphylococcus aureusBiologyBacteriaMathematicsIL-4BarrierCytotoxinsIL-13Il-17MicrobiomeType 2 Immunity

Sustainable Development Goals

SDG 0: Good health and well-being